The demise of Anti-IL-5 for asthma, or not

被引：47

作者：

O'Byrne, Paul M. ^{[1
]}

机构：

[1] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada

[2] McMaster Univ, Hamilton, ON, Canada

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2007年 / 176卷 / 11期

关键词：

D O I：

10.1164/rccm.200708-1264ED

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1059 / 1060

页数：2

共 13 条

[1] EOSINOPHILIC INFLAMMATION IN ASTHMA [J].

BOUSQUET, J ;

CHANEZ, P ;

LACOSTE, JY ;

BARNEON, G ;

GHAVANIAN, N ;

ENANDER, I ;

VENGE, P ;

AHLSTEDT, S ;

SIMONYLAFONTAINE, J ;

GODARD, P ;

MICHEL, FB .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039

[2] Eotaxin-1/CC chemokine ligand 11: A novel eosinophil survival factor secreted by human pulmonary artery endothelial cells [J].

Farahi, Neda ;

Cowburn, Andrew S. ;

Upton, Paul D. ;

Deighton, John ;

Sobolewski, Anastasia ;

Gherardi, Ermanno ;

Morrell, Nicholas W. ;

Chilvers, Edwin R. .

JOURNAL OF IMMUNOLOGY, 2007, 179 (02) :1264-1273

[3] A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma [J].

Flood-Page, Patrick ;

Swenson, Cheri ;

Faiferman, Isidore ;

Matthews, John ;

Williams, Michael ;

Brannick, Lesley ;

Robinson, Douglas ;

Wenzel, Sally ;

Busse, William ;

Hansel, Trevor T. ;

Barnes, Neil C. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (11) :1062-1071

[4] Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway [J].

Flood-Page, PT ;

Menzies-Gow, AN ;

Kay, AB ;

Robinson, DS .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (02) :199-204

[5] Anti-interieukin-5 (mepolizumab) therapy for hypereosinophilic syndromes [J].

Garrett, JK ;

Jameson, SC ;

Thomson, B ;

Collins, MH ;

Wagoner, LE ;

Freese, DK ;

Beck, LA ;

Boyce, JA ;

Filipovich, AH ;

Villanueva, JM ;

Sutton, SA ;

Assa'ad, AH ;

Rothenberg, ME .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) :115-119

[6] Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial [J].

Green, RH ;

Brightling, CE ;

McKenna, S ;

Hargadon, B ;

Parker, D ;

Bradding, P ;

Wardlaw, AJ ;

Pavord, ID .

LANCET, 2002, 360 (9347) :1715-1721

[7] Determining asthma treatment by monitoring sputum cell counts:: effect on exacerbations [J].

Jayaram, L ;

Pizzichini, MM ;

Cook, RJ ;

Boulet, LP ;

Lemière, C ;

Pizzichini, E ;

Cartier, A ;

Hussack, P ;

Goldsmith, CH ;

Laviolette, M ;

Parameswaran, K ;

Hargreave, FE .

EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) :483-494

[8] Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma - A pilot study 164/rccm.200206-5250C [J].

Kips, JC ;

O'Connor, BJ ;

Langley, SJ ;

Woodcock, A ;

Kerstjens, HAM ;

Postma, DS ;

Danzig, M ;

Cuss, F ;

Pauwels, RA .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (12) :1655-1659

[9] Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophihc syndrome [J].

Klion, AD ;

Law, MA ;

Noel, P ;

Kim, YJ ;

Haverty, TP ;

Nutman, TB .

BLOOD, 2004, 103 (08) :2939-2941

[10] Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response [J].

Leckie, MJ ;

ten Brinke, A ;

Khan, J ;

Diamant, Z ;

O'Connor, BJ ;

Walls, CM ;

Mathur, AK ;

Cowley, HC ;

Chung, KF ;

Djukanovic, R ;

Hansel, TT ;

Holgate, T ;

Sterk, PJ ;

Barnes, PJ .

LANCET, 2000, 356 (9248) :2144-2148

← 1 2 →